Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Crispr Therapeutics Ag (NQ: CRSP )

68.65 +1.92 (+2.88%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,675,382
Open 66.22
Bid (Size) 68.66 (10)
Ask (Size) 69.30 (4)
Prev. Close 66.73
Today's Range 63.39 - 68.70
52wk Range 37.55 - 76.19
Shares Outstanding 78,935,098
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Got $5,000? These Are 2 of the Best Growth Stocks to Buy Right Now
The one thing these two stocks have in common is tremendous growth prospects. 
Via The Motley Fool
An Important History Lesson for Gene-Editing Investors
Gene editing holds tremendous promise for patients and investors alike. But the road to success won't be easy. 
Via The Motley Fool

Performance

YTD
+67.44%
+67.44%
1 Month
+34.63%
+34.63%
3 Month
+36.59%
+36.59%
6 Month
+8.90%
+8.90%
1 Year
+31.74%
+31.74%

More News

Read More
5 Top Stocks to Buy Before 2024
Via The Motley Fool
Five Best Performing Stocks Of The Top ETF Of November
Via Talk Markets
Topics ETFs
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
Via The Motley Fool
Is CRISPR Therapeutics the Best Gene-Editing Stock?
Via The Motley Fool
Looking for Growth? 2 Top Stocks to Buy Hand Over Fist
Via The Motley Fool
3 Biotech Stocks That Could Be Multibaggers in the Making
Via InvestorPlace
Cathie Wood's ARK Innovation ETF Achieves 35% Gain In November, Its Best Month Since Inception
Via Benzinga
Topics ETFs
Jim Cramer: Buy Shares Of This Personal Computer Giant, Wait For 'A Little Bit Of Pullback'
Via Benzinga
3 Top-Rated Biotech Stocks That Analysts Are Loving Now
Via InvestorPlace
2 Dirt-Cheap Stocks That Could Rocket Higher in a Bull Market
Via The Motley Fool
Investing in These 3 Stocks Now Could Make You a Millionaire Retiree
Via The Motley Fool
3 Biotech Stocks That Could Be Millionaire Makers
Via The Motley Fool
Are You A Trader Or Investor: Biotech Momentum Is Picking Up
Via Talk Markets
Topics ETFs
What's Going On With Crispr Therapeutics Stock Monday?
Via Benzinga
Google’s Bard AI Says These 3 Stocks Will Rise 1,000%
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 Beaten-Down Growth Stocks That Could Rocket 42% to 67% Higher, According to Wall Street
Via The Motley Fool
Could Investing $10,000 In CRISPR Therapeutics Stock Make You a Millionaire?
Via The Motley Fool
3 Monster Stocks in the Making
Via The Motley Fool
Why CRISPR Therapeutics Stock Is Jumping Again Today
Via The Motley Fool
Ross Stores Reports Strong Earnings, Joins Buckle, Twist Bioscience And Other Big Stocks Moving Higher On Friday
Via Benzinga
Topics Stocks
Exposures US Equities
CRISPR Therapeutics Stock Earns 88 RS Rating On U.K. Regulator News
Via Investor's Business Daily
3 Long-Term Growth Stocks Analysts Are Bullish On
Via InvestorPlace
3 Cathie Wood You’ll Regret Not Buying Soon: November 2023
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.